Life Science Compliance Update

« Previous article | Home| Next article »

December 16, 2013

CME Grant Disclosures for 2012 to 3rd Quarter of 2013

We have compiled a chart of companies that have disclosed their educational grant payments for 2012-2013. Some companies have disclosure information for several years. Now that grants are subject to Sunshine Act reporting requirements for teaching hospitals, it is likely more companies will begin to post such payments to teaching hospitals. We will add additional information as it becomes available.

Company

2013 

2012 

2011 

2010

2009

Abbott

 

Q1

Q1

Q1

Q1

   

Q2

Q2

Q2

Q2

   

Q3

Q3

Q3

Q3

     

Q4

Q4

Q4

           

Allergan

Q1 & Q2

Q1 & Q2

Q1 & Q2

   
   

Q3 & Q4

Q3 & Q4

Q3

 
           

Amgen

Q1

Q1

Q1

Q1

Q1

 

Q2

Q2

Q2

Q2

Q2

 

Q3

Q3

Q3

Q3

Q3

   

Q4

Q4

Q4

Q4

           

Astellas Pharma US, Inc.

 

Q1

Q1

Q1

 
 

Q2

Q2

Q2

Q2

 
 

Q3

Q3

Q3

Q3

 
   

Q4

Q4

Q4

Q4

           

Astra Zeneca

Q1 & Q2

Q1& Q2

Q1 & Q2

Q1 & Q2

Q1 & Q2

   

Q3 & Q4

Q3 &Q4

Q3 &Q4

Q3 &Q4

           

Bristol-Myers Squibb

Q1

Q1

     
 

Q2

Q2

     
 

Q3

Q3

     
   

Q4

     
           

Forest Labs

Q1

2012 Full Year

2011 Full Year

2010 Full Year

 
 

Q2

       
 

Q3

       
           

Genentech

 

2012 Full Year

2011 Full Year

2010 Full Year

 
           

Biosense Webster

Q1 & Q2

Q3 & Q4 (starting page 3)

     

Janssen Biotech

Q1-Q3

 

 

   

Cordis

Q1 & Q2

Q3 & Q4 (starting page 3)

     
           

Depuy Mitek, Inc.

Q1 & Q2

Q3 & Q4 (starting page 3)

     
           

Depuy Orthopaedics, Inc.

Q1 & Q2

Q3 & Q4 (starting page 3)

     
           

Depuy Spine, Inc.

Q1 & Q2

Q3 & Q4 (starting page 3)

     
           

Codman and Shurtleff, Inc.

Q1 & Q2

Q3 & Q4 (starting page 3)

     
           

Ethicon

Q1 & Q2

Q3 & Q4 (starting page 3)

     
           

Janssen Pharmaceuticals, Inc.

Q1-Q3

       
           

Janessen Biotech, Inc.

Q1-Q3

 

Q1 2011

   
           

Janssen Therapeutics

Q1-Q3

       
           

Therakos

 

2012:
Q1 & Q2

2011:
Q3 & Q4 (starts page 3)

   
           

Eli Lilly

Q1-Q3

2012 Full Year

2011 Full Year

2010 Full Year

 
           

Merck

2013 Full Year (all reports available mid-page)

2012 Full Year

2011 Full Year

2010 Full Year

2009 Full Year

           

Pfizer

Q1

2012 Full Year

2011 Full Year

2010 Full Year

2009 Full Year

 

Q2

       
 

Q3

       
           

Sanofi Aventis

 

Q1

Q1

Q1

Q1

   

Q2

Q2

Q2

Q2

     

Q3

Q3

Q3

     

Q4

Q4

Q4

           

Shire

Q1

Q1

Q1

Q1

Q1

 

Q2

Q2

Q2

Q2

Q2

 

Q3

Q3

Q3

Q3

Q3

   

Q4

Q4

Q4

Q4

   

« Previous article | Home| Next article »

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e5520572bb8834019b028ee079970d

Listed below are links to weblogs that reference CME Grant Disclosures for 2012 to 3rd Quarter of 2013:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.

Newsletter


Preview | Powered by FeedBlitz

Search


 
Sponsors
September 2015
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30